超重对行胃癌根治术患者近期临床疗效的影响

发布时间：2018-05-13 17:24

本文选题：胃癌 + 超重　；参考：《西安交通大学学报(医学版)》2017年02期

【摘要】：目的探讨超重对于胃癌根治术近期疗效的影响。方法回顾性收集2009年1月至2012年12月于我科行胃癌根治术的患者166例(超重组102例,非超重组64例),比较两组患者术中、术后以及近期生存情况。结果超重组手术时间明显长于非超重组[(237.70±59.16)min vs.(210.55±54.49)min,P0.05)),术中出血量亦明显高于非超重组[(346.41±223.63)mL vs.(276.77±155.46)mL,P0.05)];两组的术中总淋巴结清扫数、肛门排气时间、进食时间、术后住院时间以及术后并发症的差异均无统计学意义。超重组和非超重组的3年生存率分别为76.8%和65.1%,差异无统计学意义(P0.05)。结论超重会延长手术时间和增加术中的出血量,但不会影响手术的近期疗效。
[Abstract]:Objective to investigate the effect of overweight on the short-term curative effect of radical gastrectomy for gastric cancer. Methods 166 patients with gastric cancer underwent radical gastrectomy from January 2009 to December 2012 were retrospectively collected, including 102 cases of superrecombination and 64 cases of non-superrecombination. The survival of the two groups during operation, postoperative and recent survival was compared. Results the operative time of superrecombination was significantly longer than that of non-superrecombination [237.70 卤54.49min P0.05, and the amount of intraoperative bleeding was significantly higher than that of non-superrecombination [346.41 卤223.63)mL vs.(276.77 卤155.46mLP0.05], the total lymph node dissection, the time of anal exhaust, and the time of feeding in the two groups were significantly longer than those in the control group. There was no significant difference in postoperative hospital stay and postoperative complications. The 3-year survival rate was 76.8% and 65.1%, respectively. There was no significant difference between the two groups (P 0.05). Conclusion overweight may prolong operative time and increase intraoperative bleeding, but it will not affect the short-term curative effect.
【作者单位】：西安交通大学第一附属医院普通外科;
【基金】：国家自然科学基金资助项目(No.81472245)~~
【分类号】：R735.2;R589.2

【相似文献】